Target intelligence / Profile preview

Tubulin beta-2A chain (TUBB2A) (TUBB2A)

Target
TUBB2A
Molecular classification
Cytoskeletal protein, Tubulin
01

Overview

Tubulin beta-2A chain (TUBB2A) is a fundamental component of the microtubule cytoskeleton, belonging to the beta-tubulin family of proteins [1.5.2, 1.5.4]. It forms heterodimers with alpha-tubulin to build microtubules, which are essential for maintaining cell structural integrity, facilitating intracellular transport, and enabling the formation of the mitotic spindle during cell division [1.5.3, 1.5.4]. As a class IIa isotype, TUBB2A is predominantly expressed in the brain and is critical for neurogenesis, neuronal migration, and cortical development [1.2.2, 1.3.1].\n\nPathogenic variants in the TUBB2A gene are associated with a spectrum of rare neurodevelopmental disorders known as tubulinopathies, which present with brain malformations, microcephaly, and infantile-onset epilepsy [1.2.2, 1.4.2]. In oncology, TUBB2A is frequently overexpressed in various cancers, such as triple-negative breast cancer and gastric cancer, where it correlates with poor prognosis and resistance to chemotherapy [1.2.1, 1.5.2]. Therapeutic agents targeting tubulin, including taxanes (e.g., paclitaxel) and vinca alkaloids (e.g., vincristine), interact with TUBB2A to disrupt microtubule dynamics, leading to cell cycle arrest and apoptosis [1.2.1, 1.3.1].

Other names
TUBB2ATUBB2CDCBM5Tubulin beta-2A class IIaβ-tubulin isotype IIaβ-tubulin – βIIa isotype
02

Mechanism of action

Microtubule stabilization and destabilization through binding to the taxane, vinca alkaloid, or colchicine sites on the tubulin heterodimer.

03

Biological functions

Microtubule formationCell divisionIntracellular transportNeuronal migrationAxon guidance
04

Disease associations

CancerNeurodevelopmental diseaseEpilepsyNeurodegenerative disease
05

Safety considerations

Peripheral neuropathyMyelosuppressionNeutropeniaChemotherapy resistance
06

Interacting drugs

Paclitaxel

6 more in the full profile.

07

Biomarkers

TUBB2A expression levelTUBB2A mutation status

Beyond the preview

Go deeper on Tubulin beta-2A chain (TUBB2A) (TUBB2A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tubulin beta-2A chain (TUBB2A) (TUBB2A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call